On the deal, Linklaters and Kirkland & Ellis advised Novo Holdings; Goodwin advised TA Associates. Novo Holdings, a holding and investment company responsible for managing the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings, Platanus, and Pureos Bioventure, as investors on the transaction. Callio Therapeutics, a biotechnology company focused on realizing the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
You must be a Standard 1 Year member to access this content.
Kromann Reumert advised Novo Holdings on the deal, and Stingray team was advised by Hjort. Novo Holdings acquired the Norwegian company Stingray Marine Solutions. Novo Holdings...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Magenta Medical (Magenta) announced that it has raised $105 million in financing. The financing was...
You must be a Standard 1 Year member to access this content.
Khaitan & Co advised Novo Holdings A/S on the deal. Novo Holdings A/S secured the acquisition of a minority stake in Agnext Technologies Private Limited (an...
You must be a Standard 1 Year member to access this content.
DORDA, Kromann Reumert and Linklaters advised Novo Holdings A/S on the transaction. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on IP Matters. Novo Holdings A/S...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Kromann Reumert are advising Novo Holdings on the transaction, Skadden, Arps, Slate, Meagher & Flom is advising Catalent, Inc. and Jones Day is...
You must be a Standard 1 Year member to access this content.
Allen & Gledhill advised Square Peg and Novo Holdings on the deal. Square Peg and Novo Holdings led the US$40.8 million series C1 extension all- equity...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
You must be a Standard 1 Year member to access this content.
On the transaction, Clifford Chance has acted for Ephios Luxembourg; Kirkland & Ellis has advised Cinven; Latham & Watkins has advised Novo Holdings A/S The Fifth...
You must be a Standard 1 Year member to access this content.
